Clinical Trials Logo

Filter by:
NCT ID: NCT00979381 Completed - Clinical trials for Renal Cell Carcinoma

Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor

Start date: October 2008
Phase: N/A
Study type: Observational

In this study the researchers investigate the influence of the tyrosine kinase inhibitors sunitinib and sorafenib, on the normal humoral and cellular immuno response to influenza vaccination in patients with metastases of renal cell carcinoma or a GIST.

NCT ID: NCT00979329 Completed - Colorectal Cancer Clinical Trials

Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST

Start date: May 2008
Phase: N/A
Study type: Observational

The purpose of this study is to assess the influence of Sunitinib and Sorafenib on fatigue, quality of life and depression in patients with metastatic renal cell or colorectal cancer or GIST. In order to get more insight in the mechanism of vascular endothelial growth factor (VEGF) related fatigue and if possible to come to a resolution for this side effect.

NCT ID: NCT00979251 Completed - Influenza Clinical Trials

Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects

PO206
Start date: September 2009
Phase: Phase 2
Study type: Interventional

This Phase 2, open label, randomized study will investigate the virologic benefit, clinical efficacy, safety, and tolerability of amantadine and ribavirin with oseltamivir (TCAD) versus oseltamivir monotherapy for the treatment of all strains of influenza A in immunocompromised adult and pediatric subjects.

NCT ID: NCT00979199 Completed - Clinical trials for Ischemic Heart Disease

Evaluation of Integrated Cardiac Imaging in Ischemic Heart Disease

EVINCI
Start date: February 2009
Phase: Phase 4
Study type: Interventional

Main purpose of the study: To comparatively assess the diagnostic performance of non invasive anatomical and functional imaging modalities to detect significant obstructive coronary artery disease as demonstrated at invasive coronary angiography and functional evaluation of coronary lesions (fractional flow reserve).

NCT ID: NCT00978393 Completed - Obesity Clinical Trials

A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers

Start date: September 16, 2009
Phase: Phase 1
Study type: Interventional

This trial is conducted in Europe. The aim of this clinical trial is to investigate the effect of liraglutide on gastric emptying, energy expenditure and appetite, and to evaluate liraglutide pharmacokinetics in non-diabetic obese volunteers. The trial is designed as a two-period, six-sequenced, crossover trial where the trial participant will enter two treatment periods with a wash-out period of 6-8 weeks.

NCT ID: NCT00977665 Completed - Clinical trials for Multiple System Atrophy

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Start date: December 2009
Phase: Phase 2
Study type: Interventional

To test the clinical effect of rasagiline on subjects with MSA of the parkinsonian subtype.

NCT ID: NCT00977483 Completed - Clinical trials for Diabetic Polyneuropathy

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)

NATHAN1
Start date: May 1998
Phase: Phase 3
Study type: Interventional

To assess clinical efficacy and safety of long-term orally administered thioctic acid in the treatment of diabetic polyneuropathy.

NCT ID: NCT00977301 Completed - HIV Infections Clinical Trials

Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)

FORZA
Start date: November 2009
Phase: Phase 1
Study type: Interventional

The effect of fosamprenavir/ritonavir (steady state) on the pharmacokinetics of a single dose of olanzapine will be studied. In this study, the investigators expect an inducible effect of fosamprenavir/ritonavir on the CYP1A2 and UGT metabolism of olanzapine.

NCT ID: NCT00977262 Completed - Obesity Clinical Trials

Postprandial Inflammation and Fatty Acids

PIFA
Start date: October 2009
Phase: N/A
Study type: Interventional

The main objective is to elucidate the acute effects of an oral intake of either saturated, monounsaturated or polyunsaturated fatty acids on peripheral blood mononuclear cells (PBMC) whole genome expression of obese and type 2 diabetic obese subjects.

NCT ID: NCT00977080 Completed - Clinical trials for Chronic Kidney Disease

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

IMPACT SHPT
Start date: November 2009
Phase: Phase 4
Study type: Interventional

Evaluates the effectiveness of on-label Paricalcitol versus Cinacalcet with Low-Dose Vitamin D.